William Hawkins

14PUBLICATIONS
142CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 22, 2026
Differential Sensitivity to xCT-inhibition by ME1 expression.

|Sep 04, 2026
Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer.

|Aug 15, 2025
Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer.

Graham D Hogg, Alyssa G Weinstein, Natalie L Kingston

|Jul 18, 2025
Trametinib Thwarts Activation of Survival Pathways Induced by Pro-ferroptotic Drug Conjugate ACXT-3102 Resulting in Enhanced Pancreatic Cancer Cell Death.

Kumar S Bishnupuri, Kenneth F Newcomer, Qingqing Gong

|May 25, 2023
Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer.

C Alston James, John M Baer, Chong Zou

|May 13, 2023
Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiology.

Usman Y Panni, Michael Y Chen, Felicia Zhang

Pageof 3

Frequent Collaborators

6 joint publications

Ryan C Fields

6 joint publications

David G DeNardo

5 joint publications

John M Herndon

4 joint publications

Varintra E Lander